Literature DB >> 23312650

Chronic fatigue syndrome.

Rona Moss-Morris1, Vincent Deary, Bronwyn Castell.   

Abstract

Chronic fatigue syndrome (CFS) is an illness characterized by disabling fatigue of at least 6 months. The aetiology of the condition has been hotly debated. In this chapter the evidence for CFS as a post viral condition and/or a neurological condition is reviewed. Although there is evidence that CFS is triggered by certain viruses in some patients and that neurobiological changes such as hypocortisolism are associated with the syndrome, neither mechanism is sufficient to explain the extent of the symptoms or disability experienced by patients. It is unlikely that CFS can be understood through one aetiological mechanisms. Rather it is a complex illness which is best explained in terms of a multifactorial cognitive behavioural model. This model proposes that CFS is precipitated by life events and/or viral illness in vulnerable individuals, such as those who are genetically predisposed, prone to distress, high achievement, and over or under activity. A self perpetuating cycle where physiological changes, illness beliefs, reduced and inconsistent activity, sleep disturbance, medical uncertainty and lack of guidance interact to maintain symptoms. Treatments based on this model including cognitive behavioural therapy and graded exercise therapy are effective at significantly reducing fatigue and disability in CFS. This chapter provides a description of these approaches and details of the trials conducted in the area.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23312650     DOI: 10.1016/B978-0-444-52901-5.00025-3

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  12 in total

Review 1.  An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides.

Authors:  Jiang Cheng; Zhi-Wei Zhou; Hui-Ping Sheng; Lan-Jie He; Xue-Wen Fan; Zhi-Xu He; Tao Sun; Xueji Zhang; Ruan Jin Zhao; Ling Gu; Chuanhai Cao; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-12-17       Impact factor: 4.162

Review 2.  The Updated NICE Guidance Exposed the Serious Flaws in CBT and Graded Exercise Therapy Trials for ME/CFS.

Authors:  Mark Vink; Alexandra Vink-Niese
Journal:  Healthcare (Basel)       Date:  2022-05-12

3.  Distinct plasma immune signatures in ME/CFS are present early in the course of illness.

Authors:  Mady Hornig; José G Montoya; Nancy G Klimas; Susan Levine; Donna Felsenstein; Lucinda Bateman; Daniel L Peterson; C Gunnar Gottschalk; Andrew F Schultz; Xiaoyu Che; Meredith L Eddy; Anthony L Komaroff; W Ian Lipkin
Journal:  Sci Adv       Date:  2015-02       Impact factor: 14.136

4.  A case of chronic fatigue syndrome improved by traditional Korean medicine.

Authors:  Chang-Gue Son
Journal:  Integr Med Res       Date:  2013-01-31

5.  Prevalence of comorbid mental and physical illnesses and risks for self-harm and premature death among primary care patients diagnosed with fatigue syndromes.

Authors:  Matthew J Carr; Darren M Ashcroft; Peter D White; Nav Kapur; Roger T Webb
Journal:  Psychol Med       Date:  2019-05-27       Impact factor: 7.723

Review 6.  Elements of Suffering in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Experience of Loss, Grief, Stigma, and Trauma in the Severely and Very Severely Affected.

Authors:  Patricia A Fennell; Nancy Dorr; Shane S George
Journal:  Healthcare (Basel)       Date:  2021-05-09

Review 7.  The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.

Authors:  Narges Moghimi; Mario Di Napoli; José Biller; James E Siegler; Rahul Shekhar; Louise D McCullough; Michelle S Harkins; Emily Hong; Danielle A Alaouieh; Gelsomina Mansueto; Afshin A Divani
Journal:  Curr Neurol Neurosci Rep       Date:  2021-06-28       Impact factor: 5.081

8.  Patient Outcomes in Association With Significant Other Responses to Chronic Fatigue Syndrome: A Systematic Review of the Literature.

Authors:  Rebecca Band; Alison Wearden; Christine Barrowclough
Journal:  Clin Psychol (New York)       Date:  2015-03-14

9.  Supplementation with Guanidinoacetic Acid in Women with Chronic Fatigue Syndrome.

Authors:  Sergej M Ostojic; Marko Stojanovic; Patrik Drid; Jay R Hoffman; Damir Sekulic; Natasa Zenic
Journal:  Nutrients       Date:  2016-01-29       Impact factor: 5.717

Review 10.  The High Costs of Low-Grade Inflammation: Persistent Fatigue as a Consequence of Reduced Cellular-Energy Availability and Non-adaptive Energy Expenditure.

Authors:  Tamara E Lacourt; Elisabeth G Vichaya; Gabriel S Chiu; Robert Dantzer; Cobi J Heijnen
Journal:  Front Behav Neurosci       Date:  2018-04-26       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.